Lea Luciani
Overview
Explore the profile of Lea Luciani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
326
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gourjault C, Pezzi L, Doudier B, Minodier P, Klitting R, Cano P, et al.
Lancet Infect Dis
. 2024 Dec;
25(2):e64-e65.
PMID: 39709970
No abstract available.
2.
Wesselmann K, Luciani L, Thirion L, de Lamballerie X, Charrel R, Pezzi L
Emerg Microbes Infect
. 2024 Nov;
13(1):2429650.
PMID: 39530886
The mosquito-borne alphavirus o'nyong-nyong virus (ONNV) has proven its potential to cause major human outbreaks. On the African continent, ONNV causes unspecific febrile illness and co-circulates with the close relative...
3.
Driouich J, Cochin M, Lingas G, Luciani L, Baronti C, Bernadin O, et al.
Biomed Pharmacother
. 2024 Jun;
177:116988.
PMID: 38897157
Therapeutic monoclonal antibodies have been successful in protecting vulnerable populations against SARS-CoV-2. However, their effectiveness has been hampered by the emergence of new variants. To adapt the therapeutic landscape, health...
4.
Petit P, Touret F, Driouich J, Cochin M, Luciani L, Bernadin O, et al.
Heliyon
. 2024 May;
10(10):e30862.
PMID: 38803975
The SARS-CoV-2 pandemic has highlighted the need for broad-spectrum antiviral drugs to respond promptly to viral emergence. We conducted a preclinical study of molnupiravir (MOV) against SARS-CoV-2 to fully characterise...
5.
Luciani L, Combe P, Touret F, Gazin C, Klitting R, Pezzi L, et al.
Heliyon
. 2024 May;
10(10):e31252.
PMID: 38803933
In endemic areas, the genetic diversity among co-circulating dengue virus (DENV) strains is considerable and new, highly divergent strains are identified on a regular basis. It is thus critical to...
6.
Jumpertz M, Sevestre J, Luciani L, Houhamdi L, Fournier P, Parola P
Emerg Infect Dis
. 2023 Mar;
29(4):701-710.
PMID: 36957992
Monitoring of tickborne diseases is critical for prevention and management. We analyzed 418 ticks removed from 359 patients during 2014-2021 in Marseille, France, for identification and bacteria detection. Using morphology,...
7.
Luciani L, Lapidus N, Amroun A, Falchi A, Souksakhone C, Mayxay M, et al.
Emerg Infect Dis
. 2022 Nov;
28(12):2463-2471.
PMID: 36343384
To determine a demographic overview of orthopoxvirus seroprevalence, we tested blood samples collected during 2003-2019 from France (n = 4,876), Bolivia (n = 601), Laos (n = 657), and Mali...
8.
Luciani L, Bichon A, Mortier C, Bourenne J, Carvelli J, Gainnier M, et al.
J Med Virol
. 2022 Oct;
95(1):e28262.
PMID: 36310370
No abstract available.
9.
Luciani L, Piorkowski G, de Lamballerie X, Van Waerebeek K, Van Bressem M
Viruses
. 2022 Sep;
14(9).
PMID: 36146656
Cetacean poxviruses (CePVs) cause 'tattoo' skin lesions in small and large cetaceans worldwide. Although the disease has been known for decades, genomic data for these poxviruses are very limited, with...
10.
Assmus F, Driouich J, Abdelnabi R, Vangeel L, Touret F, Adehin A, et al.
Microorganisms
. 2022 Aug;
10(8).
PMID: 36014057
In the absence of drugs to treat or prevent COVID-19, drug repurposing can be a valuable strategy. Despite a substantial number of clinical trials, drug repurposing did not deliver on...